Clinical Trial Update: HELIO Liver Test Performance Study in China (HEPATIC)

View source ↗

Summary

The HELIO Liver Test Performance Study in China (HEPATIC) has completed per the trial status update. Sponsor is Helio Genomics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease

Snippet

Sponsor: Helio Genomics | Conditions: Hepatocellular Carcinoma and Liver Disease | Status: COMPLETED